gdc

Biomarkers

Surviving Pregnancy and Breast Cancer
BiomarkersBreast CancerSurvivorship
With her family history of cancers related to the BRCA mutation, Jamie Ledezma’s first pregnancy suddenly got very complicated when she learned she had triple-negative breast cancer.
Tabrecta Approved for NSCLC with MET Biomarker
BiomarkersFDA Approvals, News & Updates

On May 6, 2020, the FDA approved Tabrecta (capmatinib; from Novartis), an oral kinase inhibitor, for adults with metastatic (spreading) non–small-cell lung cancer (NSCLC).

Biomarker Testing in Non–Small-Cell Lung Cancer: A Guide for Patients
BiomarkersLung Cancer

Non–small-cell lung cancer, or NSCLC, is the most common form of lung cancer, accounting for about 80% to 85% of all lung cancer cases in the United States.

What Are Biomarkers and Precision Medicine in Oncology? An Interview with W. Michael Korn, MD
BiomarkersPersonalized Medicine
Understanding the specific biomarkers associated with each patient’s cancer helps to select the best therapy that targets that unique biomarker to improve the chance of survival for that patient.
Genetic, Genomic, or Biomarker Testing in Cancer—What Is the Difference?
BiomarkersGenetics & Cancer
Genetic testing, genomic testing, molecular profiling—how can you make sense of these terms to ensure you receive the best test and best treatment in this era of targeted therapies? A group of experts and patient advocates provide answers to these questions.
Biomarker Testing Crucial for Patients with Cholangiocarcinoma
BiomarkersCholangiocarcinomaGenetics & Cancer
New treatments are becoming available for patients with cholangiocarcinoma (bile duct cancer). Testing for specific biomarkers is crucial to ensure each patient receives the best available treatment for any associated biomarker.
Biomarkers in Lung Cancer: What Are They and Why Do They Matter?
BiomarkersGenetics & CancerLung Cancer
Patients with advanced lung cancer should be tested for the 5 most common biomarkers so they may receive the best treatment options for their disease.
What on Earth Is a “Biomarker”?
Ovarian CancerBiomarkersCancer ScreeningIssue Introductions
In her Introduction to the special edition of CONQUER titled Understanding Biomarkers & Molecular Testing, Lillie D. Shockney, RN, BS, MAS, ONN-CG, briefly explains what biomarkers are, why they are important, and what you should know about them.  
Understanding Hereditary Biomarkers Versus Tumor-Specific Biomarkers—What’s the Difference?
BiomarkersGenetics & CancerPersonalized Medicine
One-size-fits-all medicine is a thing of the past. Cancer, at its core, is a genetic disease. Today’s advances in cancer research mean that doctors can now tailor a personalized treatment to the patient’s specific cancer type.
Page 1 of 2
Results 1 - 10 of 19

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country